The natural cardioprotective particle HDL modulates connexin43 gap junction channels

Cardiovascular Research

Volumn 93, Issue 1, 2012, Pages 41-49

  Morel, Sandrine ^a   Frias, Miguel A ^a   Rosker, Christian ^b   James, Richard W ^a   Rohr, Stephan ^b   Kwak, Brenda R ^a  

^a UNIVERSITY OF GENEVA   (Switzerland)

^b UNIVERSITY OF BERN   (Switzerland)

Author keywords

Connexin43; Electrical coupling; High density lipoprotein; Permeability; Phosphorylation

Indexed keywords

CONNEXIN 43; FLUORESCENT DYE; HIGH DENSITY LIPOPROTEIN; SPHINGOSINE 1 PHOSPHATE;

ANIMAL CELL; ARTICLE; CELL DEATH; ENZYME INHIBITION; EX VIVO STUDY; HEART INFARCTION SIZE; HEART MUSCLE CELL; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HEART PROTECTION; IMMUNOFLUORESCENCE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; WESTERN BLOTTING;

ANIMALS; CARDIOTONIC AGENTS; CELL COMMUNICATION; CELL DEATH; CELLS, CULTURED; CONNEXIN 43; GAP JUNCTIONS; LIPOPROTEINS, HDL; LYSOPHOSPHOLIPIDS; MYOCARDIAL REPERFUSION INJURY; MYOCYTES, CARDIAC; PHOSPHORYLATION; PROTEIN KINASE C; RATS; RATS, SPRAGUE-DAWLEY; SPHINGOSINE;

EID: 84555188589     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvr257     Document Type: Article

References (29)

1. Gordon DJ, Rifkind BM. High-density lipoprotein-the clinical implications of recent studies. N Engl J Med 1989;321:1311-1316. (Pubitemid 19267219)
2. Norata GD, Catapano AL. Molecular mechanisms responsible for the antiinflammatory and protective effect of HDL on the endothelium. Vasc Health Risk Manag 2005;1:119-129.
3. Jansen JA, van Veen TA, de Bakker JM, van Rijen HV. Cardiac connexins and impulse propagation. J Mol Cell Cardiol 2010;48:76-82.
4. Goodenough DA, Paul DL. Beyond the gap: functions of unpaired connexon channels. Nat Rev Mol Cell Biol 2003;4:285-294. (Pubitemid 36383955)
5. Solan JL, Lampe PD. Connexin43 phosphorylation: structural changes and biological effects. Biochem J 2009;419:261-272.
6. Yellon DM, Downey JM. Spotlight on preconditioning. Cardiovasc Res 2002;55: 425-428. (Pubitemid 34874937)
7. Lerner DL, Yamada KA, Schuessler RB, Saffitz JE. Accelerated onset and increased incidence of ventricular arrhythmias induced by ischemia in Cx43-deficient mice. Circulation 2000;101:547-552. (Pubitemid 30080870)
8. James RW, Proudfoot A, Pometta D. Immunoaffinity fractionation of high-density lipoprotein subclasses 2 and 3 using anti-apolipoprotein A-I and A-II immunosorbent gels. Biochim Biophys Acta 1989;1002:292-301. (Pubitemid 19101050)
9. Frias MA, Rebsamen MC, Gerber-Wicht C, Lang U. Prostaglandin E2 activates Stat3 in neonatal rat ventricular cardiomyocytes: a role in cardiac hypertrophy. Cardiovasc Res 2007;73:57-65. (Pubitemid 44937182)
10. Frias MA, James RW, Gerber-Wicht C, Lang U. Native and reconstituted HDL activate Stat3 in ventricular cardiomyocytes via ERK1/2: role of sphingosine-1-phosphate. Cardiovasc Res 2009;82:313-323.
11. Morel S, Burnier L, Roatti A, Chassot A, Roth I, Sutter E et al. Unexpected role for the human Cx37 C1019T polymorphism in tumour cell proliferation. Carcinogenesis 2010; 31:1922-1931.
12. Kwak BR, van Veen TA, Analbers LJ, Jongsma HJ. TPA increases conductance but decreases permeability in neonatal rat cardiomyocyte gap junction channels. Exp Cell Res 1995;220:456-463.
13. Kwak BR, Veillard N, Pelli G, Mulhaupt F, James RW, Chanson M et al. Reduced connexin43 expression inhibits atherosclerotic lesion formation in low-density lipoprotein receptor-deficient mice. Circulation 2003;107:1033-1039. (Pubitemid 36258728)
14. Chadjichristos CE, Morel S, Derouette JP, Sutter E, Roth I, Brisset AC et al. Targeting connexin 43 prevents platelet-derived growth factor-BB-induced phenotypic change in porcine coronary artery smooth muscle cells. Circ Res 2008;102:653-660. (Pubitemid 351457865)
15. Rohr S, Fluckiger-Labrada R, Kucera JP. Photolithographically defined deposition of attachment factors as a versatile method for patterning the growth of different cell types in culture. Pflugers Arch 2003;446:125-132. (Pubitemid 36539541)
16. Rohr S, Kucera JP. Optical recording system based on a fiber optic image conduit: assessment of microscopic activation patterns in cardiac tissue. Biophys J 1998;75:1062-1075. (Pubitemid 28357548)
17. Morel S, Milano G, Ludunge KM, Corno AF, Samaja M, Fleury S et al. Brief reoxygenation episodes during chronic hypoxia enhance posthypoxic recovery of LV function: role of mitogen-activated protein kinase signaling pathways. Basic Res Cardiol 2006; 101:336-345. (Pubitemid 43923390)
18. Herve JC, Bourmeyster N, Sarrouilhe D, Duffy HS. Gap junctional complexes: from partners to functions. Prog Biophys Mol Biol 2007;94:29-65. (Pubitemid 46782980)
19. Karliner JS. Sphingosine kinase and sphingosine 1-phosphate in cardioprotection. J Cardiovasc Pharmacol 2009;53:189-197.
20. Ek-Vitorin JF, King TJ, Heyman NS, Lampe PD, Burt JM. Selectivity of connexin 43 channels is regulated through protein kinase C-dependent phosphorylation. Circ Res 2006;98:1498-1505. (Pubitemid 44297072)
21. Bastiaanse EM, Jongsma HJ, van der Laarse A, Takens-Kwak BR. Heptanol-induced decrease in cardiac gap junctional conductance is mediated by a decrease in the fluidity of membranous cholesterol-rich domains. J Membr Biol 1993;136: 135-145. (Pubitemid 23353235)
22. Saffitz JE, Hames KY, Kanno S. Remodeling of gap junctions in ischemic and nonischemic forms of heart disease. J Membr Biol 2007;218:65-71. (Pubitemid 350132117)
23. Karliner JS, Honbo N, Summers K, Gray MO, Goetzl EJ. The lysophospholipids sphingosine-1-phosphate and lysophosphatidic acid enhance survival during hypoxia in neonatal rat cardiac myocytes. J Mol Cell Cardiol 2001;33: 1713-1717. (Pubitemid 32844228)
24. Rohr S, Kucera JP, Kleber AG. Slow conduction in cardiac tissue, I: effects of a reduction of excitability versus a reduction of electrical coupling on microconduction. Circ Res 1998;83:781-794. (Pubitemid 28489075)
25. Shaw RM, Rudy Y. Ionic mechanisms of propagation in cardiac tissue. Roles of the sodium and L-type calcium currents during reduced excitability and decreased gap junction coupling. Circ Res 1997;81:727-741. (Pubitemid 27467208)
26. Calabresi L, Rossoni G, Gomaraschi M, Sisto F, Berti F, Franceschini G. High-density lipoproteins protect isolated rat hearts from ischemia-reperfusion injury by reducing cardiac tumor necrosis factor-alpha content and enhancing prostaglandin release. Circ Res 2003;92:330-337. (Pubitemid 36258556)
27. Gomaraschi M, Calabresi L, Rossoni G, Iametti S, Franceschini G, Stonik JA et al. Anti-inflammatory and cardioprotective activities of synthetic high-density lipoprotein containing apolipoprotein A-I mimetic peptides. J Pharmacol Exp Ther 2008;324: 776-783. (Pubitemid 351185837)
28. Imaizumi S, Miura S, Nakamura K, Kiya Y, Uehara Y, Zhang B et al. Antiarrhythmogenic effect of reconstituted high-density lipoprotein against ischemia/reperfusion in rats. J Am Coll Cardiol 2008;51:1604-1612. (Pubitemid 351508363)
29. Jin ZQ, Zhou HZ, Zhu P, Honbo N, Mochly-Rosen D, Messing RO et al. Cardioprotection mediated by sphingosine-1-phosphate and ganglioside GM-1 in wild-type and PKC epsilon knockout mouse hearts. Am J Physiol Heart Circ Physiol 2002;282: H1970-1977. (Pubitemid 34663002)